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Background: The EQ-5D is a health-related quality of life instrument which provides a simple descriptive health
profile and a single index value for health status. The latest version, the EQ-5D-5L, has been translated into more
than one hundred languages worldwide - including Thai. This study aims to assess the measurement properties of
the Thai version of the EQ-5D-5L (the 5L) compared to the EQ-5D-3L (the 3L).
Methods: A total of 117 diabetes patients treated with insulin completed a questionnaire including the 3L and the
5L. The 3L and 5L were compared in terms of distribution, ceiling, convergent validity, discriminative power,
test-retest reliability, feasibility, and patient preference. Convergent validity was tested by assessing the relationship
between each dimension of the EQ-5D and SF-36v2 using Spearman’s rank-order correlation. Discriminative power
was determined by the Shannon index (H ′) and Shannon’s Evenness index (J ′). The test-retest reliability was
assessed by examining the intraclass correlation coefficient (ICC) and Cohen’s weighted kappa coefficient.
Results: No inconsistent response was found. The 5L trended towards a slightly lower ceiling compared with the
3L (33% versus 29%). Regarding redistribution, 69% to 100% of the patients answering level 2 with the 3L version
redistributed their responses to level 2 with the 5L version while about 9% to 22% redistributed their responses to
level 3 with the 5L version. The Shannon index (H ′) improved with the 5L while the Shannon's Evenness index (J ′)
reduced slightly. Convergent validity and test-retest reliability was confirmed for both 3L and 5L.
Conclusions: Evidence supported the convergent validity and test-retest reliability of both the 3L and 5L in
diabetes patients. However, the 5L is more promising compared to the 3L in terms of a lower ceiling, more
discriminatory power, and higher preference by the respondents. Thus, the 5L should be recommended as a
preferred health-related quality of life measure in Thailand.
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The EQ-5D - a widely used generic instrument for
describing and valuing health outcomes in clinical and
economic evaluations - was originally developed in the
1980s [1,2]. Due to its simplicity and brevity, it imposes
minimal respondent burden and can be administered
using a variety of modalities including self-completion.* Correspondence: montarat.tha@mahidol.ac.th
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this article, unless otherwise stated.Many health technology assessment (HTA) organi-
zations including the National Institution for Clinical
Excellence (NICE) [3], the US panel on Cost-effectiveness
in Health and Medicine [4], and the Thai national guide-
line of HTA [5] have recommended the EQ-5D as the
preferred method for assessing the utility for health tech-
nology assessment.
The EQ-5D comprises 2 parts: a simple descriptive pro-
file that can be converted into a single summary index
(the EQ-5D index), and a visual analog scale (VAS). At
present, the first version of the EQ-5D - known as
EQ-5D-3L version (hereafter “the 3L”) - has now been
translated into more than 140 languages [6]. The 3L; licensee BioMed Central. This is an Open Access article distributed under the
icense (http://creativecommons.org/licenses/by/4.0), which permits unrestricted
ium, provided the original work is properly credited. The Creative Commons
ivecommons.org/publicdomain/zero/1.0/) applies to the data made available in
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ity; self-care; usual activities; pain/discomfort; and anxiety/
depression. Each dimension has three levels of impairment,
namely no problems (level 1), some/moderate problems
(level 2), and extreme problems (level 3). The descriptive
response from the EQ-5D can be converted into an index
score which is useful for clinical and economic evaluations
[2]. For the VAS, a respondent will be asked to rate their
health on a 20-centimeter vertical scale. The scale ranges
from 0 to 100, where 0 means the worst possible health
that the respondent can imagine and 100 indicates the
best possible health in the respondent’s viewpoint.
Since the 3L is limited to three levels of response
categories, a substantial ceiling effect was observed
[7-12]. In addition, it has limitations in measuring small
changes, especially in mild conditions [13-16]. Previous
studies also found that the 3L appeared to be less sen-
sitive when compared to the SF-12 or SF-36 [7,8]. In
response to the problems previously mentioned, the
5-level of EQ-5D (EQ-5D-5L, hereafter “the 5L”) was
developed by a task force within the EuroQol group
[13,14]. This version includes five levels of impairment
in each of the existing five EQ-5D dimensions. At
present, the 5L has now been translated into more than
113 languages [17]. Several studies [15,16,18-24] exami-
ning the measurement properties of the 5L have found
that it is a valid and reliable instrument. When com-
paring the 5L with the 3L, it was found that the 5L had
a lower ceiling effect [16,18-21,23,24] and greater
discriminative power with the potential to better detect
the differences between groups [15,16,18,20,21,24]. In
addition, it showed better face validity [13,15,25] and
test-retest reliability [18,21,23].
Previous studies were conducted in several countries
to evaluate the measurement properties of the 3L com-
pared to those of the 5L [15,16,18-24]. However, there is
a substantial need to assess the measurement properties
of the 5L in different populations and patients. The Thai
version of EQ-5D-5L has been available since 2013 but
there has been no assessment of its measurement prop-
erties in Thailand to our knowledge. Therefore, this
study aims to examine this issue and to assess the mea-
surement properties of the 5L in comparison with the
3L among diabetes mellitus patients treated with insulin.
The measurement properties will be assessed in terms of
distribution; redistribution; ceiling; convergent validity;




A convenience sample of patients with diabetes mellitus -
who received treatment at the outpatient department at
Ramathibodi Hospital, Thailand during 7 January and 31March 2013 - was invited to participate in this study.
Patients were eligible if they met the following criteria:
aged ≥ 12 years, required regular insulin treatment, and
had no complications as determined by the nurse. Preg-
nant women and disabled persons were excluded from
this study.
Procedure and instruments
The questionnaire consisted of 4 parts: 1) one page of
the Thai version of the 3L and 5L response scale; 2) the
EQ-VAS; 3) two preference questions; and 4) the short-
form 36 health survey version 2 (SF-36v2) in Thai. The
permission to use the official Thai version of the 3L, 5L,
and SF-36v2 was granted by the authoritarians before
beginning the data collection process.
The single page of the 3L and 5L response scale con-
tained the 5L version on the left column and the 3L ver-
sion on the right column. Similar to previous studies
[15,18,20], respondents were asked to complete the 5L
first, followed by the 3L in order to avoid the tendency
to not choose levels 2 and 4 - the “in-between” options -
when the 3L was completed first. The index value of the
5L was obtained from an interim mapping generated by
the EuroQol group [26] as the valuation study of the 5L
in Thailand has not yet been completed. The 3L index
value was calculated using the Thai value sets studied by
Tongsiri et al. [27].
The preference questions comprised 2 items: 1) Which
response scale is easier to use? (the 3L or the 5L or in-
different); and 2) Which response scale best describes
your health? [15].
The convergent validity of the 5L and 3L were eva-
luated by comparing them with the SF-36 as it is a
widely-used generic health survey in clinical research
and has demonstrated validity among the Thai popu-
lation [28-30]. The SF-36 contains 8 dimensions, i.e.
physical functioning; role limitation due to physical
problems; bodily pain; general health perceptions; social
functioning; vitality; role limitations due to emotional
problems; and general mental health [31]. Since a
weighted Likert scale is used as the scoring system, the
items for each dimension are summed to provide a score
which is then linearly transformed into a value from
0 – 100 (100 indicating the best health level).
This study was approved by the Mahidol University
Institutional Review Board (MU-IRB), Thailand and the
Institute for the Development of Human Research Pro-
tections (IHRP), Ministry of Public Health, Thailand. All
participants provided written informed consent and all
instruments were self-administered. After completing
the questionnaire, the respondents received 3.25 USD
for compensation (1 USD = 30.73 Baht). All respondents
were also asked to complete a second set of question-
naires after 2 weeks and to return it by mail; the set
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scale and the EQ-VAS. If the second questionnaire did
not reach the researcher within 3 days after due date,
phone call or short message was made to remind the re-
spondent. The second questionnaires which reached to
the researcher later than 21 days were excluded from the
analysis.
Statistical analyses
The distribution of the 3L and 5L responses was demon-
strated in terms of percentage of each level reported.
The redistribution patterns of the responses from the 3L
to 5L for each dimension were also reported in terms of
percentage. Similar to previous studies [15,21], the re-
sponse inconsistency and size were determined and are
shown in Table 1. To determine the inconsistency, the
response of the 3L was converted into the 5L (the 3L5L)
as follows: 1 = 1, 2 = 3, and 3 = 5. Then, the size of in-
consistency was calculated as |3L5L-5L|-1. A size of
inconsistency of ≤ 0 indicated consistency, and thus only
7 pairs are considered as consistent responses.
For the ceiling, the proportion of respondents reported
‘no problems’ for all five dimensions - the proportion of
respondents scoring ‘11111’ [16] - was compared for the
3L and 5L. The percentage reduction from the 5L to 3L
was calculated as follows: (Ceiling 3L – Ceiling 5L)/
Ceiling 5L. We hypothesized that the ceiling should be
lower in the 5L compared with the 3L. Feasibility was
assessed by calculating the number of missing values for
the 5L and 3L.
Convergent validity was tested by assessing the relation-
ship between each dimension of the 5L and SF-36v2 using
Spearman’s rank-order correlation (Spearman’s rho). We
hypothesized that each dimension in the 5L would be
more highly correlated to related subscales than to other
subscales in the SF-36 compared to the 3L. Specifically,
we expect to see strong correlation between these pairs
of subscales: mobility and physical functioning; pain and
bodily pain; anxiety/depression and mental health. We
also expected to identify moderate correlation between
these pairs of subscales: self-care and physical functioning
or role limitation due to physical problems; usual activity
and role limitation due to physical problems. The EQ-5D’s
responses were recoded to signify that higher scores pre-
sented better health statuses. The strength of correlationTable 1 Size of (in) consistent response
3L
5L
Level 1 Level 2 Level 3 Level 4 Level 5
level 1 -1 0 1 2 3
level 2 1 0 -1 0 1
level 3 3 2 1 0 -1
Adapted from Janssen et al [16]. The size of inconsistency of ≤ 0 indicated
consistency.was determined as follows: absent (r < 0.20), weak associ-
ation (0.2 ≤ r < 0.35), moderate (0.35 ≤ r < 0.50), and strong
(r ≥ 0.50) [32]. Additionally, the relationship between VAS
score and index value was reported using the Pearson’s
correlation coefficient.
Discriminative power (or informativity) was determined
by the Shannon index (H ′) and Shannon’s Evenness index
(J ′). H ′ and J ′ are often used to reflect the discriminatory
power of health state classification [15,16,18,21,33]. H ′ re-
flects the absolute information content. The higher the H ′,
the more information is captured by the measure. On the
other hand, J ′ expresses the relative informativity of a
system or the evenness of a distribution regardless of the
number of categories. In case of an even distribution -
when all levels are filled with the same frequency - J ′ is
equal to 1. When comparing the 5L to the 3L, we expect
the H ′ of the 5L to be higher to reflect more discrimin-
atory performance. On the other hand, the J ′ of the 5L
might slightly decrease as the extra level might not be
used equally.
The test-retest reliability of both EQ-5D index scores
was evaluated using the intraclass correlation coefficient
(ICC) and the reliability of each dimension was assessed
with Cohen’s weighted kappa coefficient. According to
Fleiss’s standards for the strength of agreement for kappa
values [34], Cohen’s weighted kappa (k) was determined
as follows: poor reproducibility (k < 0.4); good reproduci-
bility (0.4 ≤ k < 0.75; excellent reproducibility (k ≥ 0.75).
Regarding intra-rater reliability among each dimension
at different times, the data set lacked variance since
most respondents responded with level 1 for self-care.
The weighted kappa coefficient could not be calculated,
thus percentage agreement values was demonstrated also
[35,36]. It was calculated as: (a + d)/N, where the values
of a and d were obtained from a 2x2 table.
All data were analyzed using SPSS 19. Statistical sig-
nificance was set a priori as p < 0.05.
Results
Characteristics of respondents
A total of 117 patients with diabetes mellitus who met
the eligibility criteria were included. The characteristics
of the respondents are shown in Table 2. The average
age of the respondents was 45 years, with 62.4% being
female. Sixty-four (54.7%) respondents had type 2 dia-
betes. The average diabetes duration of the sample was
9 years and the average BMI was 23.30. Of the 117
respondents who completed the first survey, 101 respon-
dents (86%) returned the second questionnaire set by
postal mail.
The health state ‘11111’ was observed in 29.1% in the
5L and 33.3% for the 3L. The second-most frequent
health state reported was ‘11121’ which was 14.5% in the
5L and 15.4% in the 3L. Finally, there were no missing
Table 2 Demographic characteristic of respondents
Demographic characteristic n (%)
Type of diabetes
Type 1 53 (45.3)










High school 51 (43.6)
Primary school 27 (23.1)
Bachelor’s degree 25 (21.4)
Diploma 10 (8.5)
Master’s degree or higher 4 (3.4)
Occupation
Student 50 (42.7)
Government/state enterprise officer 20 (17.1)
Housewife 14 (12.0)
Business owner 11 (9.4)






Civil Servants Medical Benefits Scheme 58 (49.6)
Out of pocket 32 (27.4)
Universal coverage 20 (17.1)
Social security 7 (6.0)
Median (IQR)
Age (years) 45.00 (40.0)
Diabetes duration (yr) 9.00 (8.50)
BMI (Kg/M2) 23.30 (7.37)
Household income per month (Baht) 30,000 (30,000)
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feasibility for both instruments.
Distribution and ceiling
For all of the dimensions, most respondents reported no
problems (level 1) for both the 3L (52-98%) and the 5L
(44-97%), as shown in Figure 1. Among responses withhealth problems, it was clear that the 5L demonstrated
better severity level distribution than the 3L except for
self-care.
With regards to the ceiling, the 5L showed a slightly
decreasing trend for no problem responses compared
with the 3L. The percentage of patients reporting the
health state ‘11111’ decreased from 33% in the 3L to
29% in the 5L. Nevertheless, no statistically significant
difference was found. Self-care reached the highest cei-
ling (98% for the 3L, 97% for the 5L) and showed the
smallest reduction in ceiling (1%) with the 5L. In con-
trast, pain/discomfort showed the smallest ceiling (52%
for the 3L, 44% for the 5L) and also showed statistically
significant reduction in ceiling with the 5L. No statis-
tically significant reduction was found for the other
dimensions.
Redistribution
Among the answers of no problem (level 1) on the 3L,
most of them (85-98%) remained the same (no problem)
on the 5L while 2-15% redistributed to slight problems
(level 2) on the 5L as shown in Table 3. The majority of
the respondents who reported moderate problems (level
2) on the 3L indicated slight problems (level 2) on the
5L (69-100%), while 9-22% shifted to moderate problems
(level 3) on the 5L. As such, redistribution occurred the
least in self-care. The mean VAS score tended to be
lower according to the severity level of the 5L. No in-
consistent response was found in this study.
Convergent validity
Table 4 demonstrates the Spearman’s correlation coeffi-
cients between the EQ-5D and SF-36v2 dimensions. In
general, the pattern of correlations between the 2 ver-
sions of EQ-5D and SF-36v2 was similar. As expected,
stronger correlation between similar dimensions of EQ-
5D and SF-36v2 were found: mobility and physical func-
tioning (r = 0.54 for the 3L, r = 0.53 for the 5L); pain/
discomfort and bodily pain (r = 0.30 for the 3L, r = 0.35
for the 5L); anxiety/depression and mental health (r = 0.45
for the 3L, r = 0.49 for the 5L). However, self-care and
usual activity dimension of the EQ-5D were weakly asso-
ciated with various dimensions of SF-36v2. Additionally,
Pearson’s correlation coefficient between the VAS score
and index value was also similar between the 3L and 5L
(0.36 for the 3L, 0.35 for the 5L with p-value < 0.001).
Discriminative power
The absolute informativity (H ′) of the 5L was higher
than the 3L for all dimensions as shown in Table 5. This
reflects that the 5L generated more informativity than
the 3L. We also found that the 5L generated similar

































































Figure 1 Distribution across severity level of the 3L and 5L dimension.
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The time interval between the first and second test was
approximately 3 weeks. Overall, the reliability coefficient
and percentage agreement of the 5L were slightly lower
than the 3L (Table 6). The weighted kappa coefficient
for the 3L ranged between 0.39 and 0.70, and betweenTable 3 Redistribution pattern of response from 3L to 5L
Dimension 3L 5L n (%) Mean VAS Size of
inconsistent
response*
Mobility 1 1 83 (98%) 81.02 −1
2 2 (2%) 85.00 0
2 2 22 (69%) 72.38 0
3 7 (22%) 71.43 −1
4 3 (9%) 72.67 0
Self-care 1 1 113 (98%) 79.19 −1
2 2 (2%) 70.00 0
2 2 2 (100%) 60.00 0
Usual activities 1 1 93 (98%) 80.82 −1
2 2 (2%) 80.00 0
2 2 20 (91%) 71.85 0
3 2 (9%) 50.00 −1
Pain/discomfort 1 1 52 (85%) 81.54 −1
2 9 (15%) 86.33 0
2 2 45 (80%) 77.77 0
3 10 (18%) 64.50 −1
4 1 (2%) 50.00 0
Anxiety/depression 1 1 84 (94%) 81.38 −1
2 5 (6%) 71.80 0
2 2 23 (82%) 73.48 0
3 4 (14%) 67.50 −1
4 1 (4%) 60.00 0
*The size of inconsistency of ≤ 0 indicated consistency.0.44 and 0.57 for the 5L; this indicated that the 3L had
better reproducibility than the 5L. The percentage agree-
ment returned higher values than the weighted kappa
coefficient; it was between 0.78 and 0.98 for the 3L and
0.67 and 0.97 for the 5L. The ICCs of the 3L and 5L in-
dexes were 0.64 and 0.70, respectively, which indicated
excellent reproducibility for both instruments.Patient preferences
Thirty-six percent of respondents indicated that the 5L
was easier to answer than the 3L while 33% of respon-
dents indicated that there was no difference between the
5L and the 3L. In terms of reflecting health status, most
respondents (63%) agreed that the 5L was better inTable 4 Correlation coefficients between EQ-5D and
SF-36v2 dimensions
Dimension PF RP BP GH VT SF RE MH
3L
Mobility .54** .28** .41** .42** .25** −0.07 0.11 0.14
Self-care 0.16 0.05 .19* 0.12 0.14 0.16 0.06 0.18
Usual activities .25** .21* .30** .19* .27** 0.18 0.13 .28**
Pain/discomfort .19* 0.17 .30** .24** .18* 0.11 .21* .22*
Anxiety/depression 0.05 0.09 .23* .22* .21* .32** .29** .45**
5L
Mobility .53** .29** .44** .44** .23* −0.08 0.09 0.11
Self-care .24** .20* .23* 0.18 0.16 .24** .21* .22*
Usual activities .30** .23* .29** .22* .24* 0.16 0.14 .24**
Pain/discomfort .24** .23* .35** .28** .22* 0.08 0.16 0.18
Anxiety/depression 0.08 0.12 .19* .21* .28** .35** .29** .49**
PF (physical functioning), RP (role limitation due to physical problems),
BP (bodily pain), GH (general health perceptions), SF (social functioning),
VT (vitality), RE (role limitations due to emotional problems), MH (general
mental health).
*Correlation is significant at the 0.05 level (2-tailed).
**Correlation is significant at the 0.01 level (2-tailed).
Table 5 Shannon’s index (H ′) and Shannon’s Evenness
index (J ′) of 3L and 5L
Dimension
H ′ J ′
3L 5L 3L 5L
Mobility 0.85 1.20 0.53 0.52
Self-care 0.12 0.21 0.08 0.09
Usual activities 0.70 0.78 0.44 0.34
Pain/discomfort 1.00 1.40 0.63 0.60
Anxiety/depression 0.79 1.06 0.50 0.46
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both versions were similar.
Discussion
This report is the first study in Thailand that assesses the
measurement properties of the 5L and compares it with
the 3L. Similar to previous studies [16,18,20,21,23,24],
self-care showed the highest percentage of ceiling effect in
both the 3L and 5L. On the other hand, the lowest ceiling
was found in pain/discomfort (44%) [18,21,23]. Similar to
the previous studies [16,18-21,23,24], the proportion of
the ceiling in our study was lower in the 5L (29%) com-
pared with the 3L (33%). However, in the previous studies
that involved patients with a variety of severity higher re-
duction in ceiling of the 5L (3-17%) was identified
[16,18,21,23]. The smaller reduction in ceiling found in
our study is probably due to the fact that our respondents
were likely to perceive that they were healthy, which was
consistent with their median VAS score of 0.78. In fact,
our finding is similar to those of the previous study [20],
which found a slight reduction in ceiling effect among
participants; whose median VAS score was 80.
In each dimension, more than half of the responses were
in level 1 (no problem) for both the 3L and 5L. In
addition, we found that the majority of level 1 in the 3L
still remained at level 1 in the 5L (85-98%) while only 2%
(self-care) to 15% (in pain/discomfort) were upgraded to
level 2 in the 5L. The redistribution from 3L-level 2 (some
problems) to 5L-level 2 (slight problems) was also high,Table 6 Test-retest reliability of the 3L and the 5L
Dimension
Weighted kappa coefficient (95% CI)
3L 5L
Mobility 0.70 (0.53-0.86) 0.57
Self-care n/a* n/a
Usual activities 0.39 (0.16-0.62) 0.45
Pain/discomfort 0.56 (0.39-0.72) 0.44
Anxiety/depression 0.50 (0.31-0.70) 0.49
Intraclass correlation coefficient (ICC)
EQ-5D index 0.64 (0.51-0.74) 0.70
*Not enough information to calculate kappa coefficient for self-care dimension.
**ICC was 2-way random, single measures, and absolute agreement.ranging from 69% for mobility to 100% for self-care. On
the other hand, redistribution from 3L-level 2 to 5L-level
3, ranging only from 9% for usual activities to 22% for mo-
bility. This is probably due to the fact that most respon-
dents in our study perceived that they were healthy and
have no problem. In addition, for those who indicated
having some problems in the 3L they are more likely to
have slight problems rather than moderate problems. This
finding supports that the 5L can present more details of
severity than the 3L and that the inclusion of the slight
problems (level 2) in the 5L is essential, especially when
the respondents were in mild condition. However, no sup-
portive evidence of the inclusion of severe problems (level
4) in the 5L was found in our study as no 3L-level 3 re-
sponses were reported. Again, this may also be due to the
fact that our respondents were likely to perceive that they
were healthy.
No inconsistent responses were found in our study.
This indicates that our respondents were able to consist-
ently answer both the 3L and 5L. This is similar to pre-
vious studies [15,18,20,21,23,24] which showed that
inconsistency was quite low, ranging from 0.5% to 3.5%.
However, the consistent responses may be due to the
low number of the sample size and the characteristics of
our sample - educated and healthy diabetic patients.
In addition, even when the respondents completed the
questionnaires themselves, they were well-advised by
trained staff. However, it should be noted that the single
page of the 3L and 5L response scale used in this study
was against the standards for the EQ-5D which should
be used separately in one page A4 format. As the result,
the answers from the 3L and the 5L may not be totally
independent and might generate less reliable results.
The measurement of reliability and agreement is im-
portant in health classification as it reveals the amount
of errors of the measurement. The concept of ‘reliability’
differs from ‘agreement’ in that reliability is a relative
measure which is the ratio of variability between sub-
jects to the total variability of all measurement in the
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ment is an absolute measure which is the degree to
which responses are identical. Cohen’s weighted kappa is
often used in assessing test-retest reliability of ordinal
instruments as it takes the chance agreement into ac-
count. However, the lack of variance in the data set
meant that the kappa could not be calculated so it was
necessary to rely on the percentage agreement values.
However, it should be cautioned that the percentage
agreement may give higher reproducibility figures than
the kappa coefficient [35].
Unlike previous studies [21,23,24], our results of the
test-retest reliability/agreement showed that the 5L was
slightly less reproducible than the 3L in all dimensions.
This is probably due to the fact that the average time
interval between the two tests was too long (approxi-
mately 14–21 days) so the condition of the patients
might have changed [36]. If this is the case there is a
higher chance of distorting the 5L results as the 5L is
better than the 3L in capturing small changes in health
status. In fact, a simple question such as “Has your
health changed significantly since last time you filled in
the questionnaire?” should be added and only patients
whose conditions were stable should be included in the
test-retest analysis. Since there is no check whether
health status of the patients was changed or remained
the same the result of test-retest reliability should be
interpreted with cautions.
Convergent validity was evaluated by correlations be-
tween the EQ-5D and SF-36v2 dimensions. Both the 3L
and 5L presented an acceptable degree of association
and similar correlation pattern with the SF-36v2 in some
pairs of dimension, i.e. mobility versus physical function-
ing; pain/discomfort versus bodily pain; and anxiety/de-
pression versus mental health. The findings were similar
to the study by Kimman et al. [28] that assessed the rela-
tionship of the 3L with the SF-36v2 among the occupa-
tional population in Thailand.
Similar to previous studies [15,16,20], absolute infor-
mativity (H ′) increased in all dimensions for the 5L while
in terms of the evenness of distribution evaluated by
Shannon’s Evenness index (J ′), the 5L was comparable to
the 3L. While the maximum value of H′ for the 5L is 2.32,
our H′ values ranged from 0.21 to 1.40 which was lower
than the findings from Pickard et al. [16] (0.84-2.00) and
Janssen et al. [15] (2.05-2.26). With the maximum value
of J ′ set at 1.00, our J ′ values ranged from 0.09 to 0.60
which was also lower than Pickard et al. [16] (0.36-0.86)
and Janssen et al. [15] (0.88-0.97). The lower H ′ and J ′
values found in our study may have risen from the mild
characteristic of our sample since the extreme problems
(3L-level 3 and 5L-level 5) were not reported. As the re-
sult, the levels of responses of the EQ-5D were used inef-
fectively, resulting in low H ′ and J ′ values.In our study, diabetic mellitus was chosen as it is a
common chronic disease that substantial affects quality
of life [37,38]. Additionally, diabetes was ranked as third
and eighth in terms of Disability Adjusted Life Year
(DALY) loss in Thai women and men, respectively [39].
We included patients with no complications in our study
to ensure that the health status will be stable enough in
order to test the test-retest reliability/agreement. How-
ever, given the mild condition of our sample, we were
unable to assess the redistribution of answers from the
3L-level 3 to the 5L.
Further studies should be conducted for patients with
a variety of severe health problems. In addition, it should
be noted that the generalizing of the findings to different
groups of patients should be made with caution as the
pattern of responses may differ by disease characteristics
[8]. One further limitation is that the 5L index values
were obtained from the interim mapping generated by
the EuroQol group since the valuation study for the 5L
in Thailand has not been completed yet. Although the
calculation was based on the Thai 3L value sets, the re-
sults of the mapping may deviate compared to the actual
responses [40]. In addition, it is also worth noting that
about 20% of our respondents were in the age 12–15
years old. Although the use of adult version may be
allowed among this age group of respondents there is
very limited evidence on the suitable of the use of adult
version especially in term of validity and reliability
among this group of respondents.
Conclusions
In summary, this study suggests that the 5L was greater
than the 3L in terms of distribution, ceiling, informa-
tivity, discriminatory power, and patient preferences.
The 5L also showed reasonable convergent validity and
test-retest reliability. Thus, the 5L should be recom-
mended for use in research or clinical practice and can
also be used as a preferred health-related quality of life
questionnaire in Thailand.
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